| ICD10 Disease Category |
Disease Name |
ICD10 Code |
Linked Targets |
| N00-N99: Diseases of the genitourinary system |
Urinary incontinence |
N39.3, N39.4, R32 |
TRPV1 |
| R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Acute or chronic pain |
R52, G89 |
TRPV1 |
| G00-G99: Diseases of the nervous system G00-G99 |
Acute migraine |
G43 |
TRPV1 |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Obesity |
E66 |
CNR1; CNR1; CNR1; CNR1; CNR1; CNR1 |
| F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Schizophrenia |
F20 |
CNR1 |
| F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Anxiety disorder |
F32, F40-F42 |
FAAH |
| F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Anorexia |
F50.0-F50.1 |
CNR1 |
| M00-M99: Diseases of the musculoskeletal system and connective tissue |
Rheumatoid arthritis |
M05-M06 |
CNR2 |
| C00-D49: Neoplasms |
Cancer |
C00-C96 |
NFKB1 |
| R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Anesthesia |
R20.0 |
FAAH |
| A00-B99: Certain infectious and parasitic diseases |
Postherpetic neuralgia |
B02.2, G44.847, G53.0 |
CNR1; TRPV1 |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Fabry's disease |
E75.2 |
GLA |
| I00-I99: Diseases of the circulatory system |
Cerebrovascular ischaemia |
I61-I63 |
CNR1 |
| R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Chemotherapy-induced nausea |
R11 |
CNR1 |
| D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism |
Immune disorder |
D80-D89 |
CNR2 |
| R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Chronic pathological pain |
R52, G89 |
TRPV1 |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Endocrine disease |
E00-E35 |
CNR1 |
| I00-I99: Diseases of the circulatory system |
Hypertension |
I10-I16 |
CNR1 |
| R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Musculoskeletal pain |
R52, G89 |
TRPV1 |
| NA: NA |
Esophagus sensitivity |
NA |
TRPV1 |
| C00-D49: Neoplasms |
Thyroid cancer |
C73 |
TSHR |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetes |
E23.2, N25.1 |
CNR1; CNR1; CNR1 |
| R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Cough |
R05 |
TRPV1 |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic disorders |
E70-E89 |
CNR1; CNR1 |
| K00-K95: Diseases of the digestive system |
Gastroesophageal reflux disease |
K21 |
TRPV1 |
| W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure |
Diagnostic test to differentiate primary and secondary hypothyroidism |
W88 |
TSHR |
| F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Drug abuse |
F10-F19 |
CNR1 |
| L00-L99: Diseases of the skin and subcutaneous tissue |
Atopic dermatitis |
L00-L99 |
CNR2; TRPV1 |
| F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Major depressive disorder |
F32, F33, M32 |
FAAH |
| J00-J99: Diseases of the respiratory system |
Asthma |
J45 |
TRPV1 |
| K00-K95: Diseases of the digestive system |
Liver disease |
K70-K77 |
FAAH |
| G00-G99: Diseases of the nervous system G00-G99 |
Central nervous system disease |
G00-G99 |
CNR1 |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Lipid metabolism disorder |
E75-E78 |
CNR1 |
| C00-D49: Neoplasms |
Overactive bladder disorder |
C67, N32.81 |
TRPV1; TRPV1 |
| C00-D49: Neoplasms |
Ovarian cancer |
C56 |
CNR1 |
| M00-M99: Diseases of the musculoskeletal system and connective tissue |
Osteoporosis |
M80-M81, Z79.890 |
CNR2 |
| I00-I99: Diseases of the circulatory system |
Ischemia |
I99.8 |
CNR1 |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Type 2 diabetes |
E11 |
CNR1; NFKB1 |
| G00-G99: Diseases of the nervous system G00-G99 |
Pain |
G64, G90.0, R52, G89 |
CNR1; FAAH; CNR2; TRPV1; TRPV1 |
| K00-K95: Diseases of the digestive system |
Inflammatory bowel disease |
K50, K51 |
CNR2 |
| C00-D49: Neoplasms |
Inflammatory disease |
C11, C44, K75.9, M00-M25 |
FAAH; CNR2 |
| F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Insomnia |
F51.0, G47.0 |
CNR1 |
| F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Psychotic disorders |
F20-F29 |
CNR1 |
| C00-D49: Neoplasms |
Thyroid cancer diagnosis |
C73 |
TSHR |
| E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic neuropathy |
E11.40 |
TRPV1 |
| G00-G99: Diseases of the nervous system G00-G99 |
Neuropathic pain |
G64, G90.0 |
CNR1; CNR2; TRPV1 |
| F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Nicotine dependence |
F17 |
CNR1 |
